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Abstract  
This study aimed (i) to assess the ability of electronic nose (e-nose) technology to differentiate 
between blood samples of experimentally infected and non-infected subjects, and (ii) to evaluate 
e-nose responses given by volatile organic compounds in relation to the acute phase reaction 
generated in the host. In an animal model of gram-negative bacterial infection (20 calves; 
intratracheal inoculation of Mannheimia haemolytica A1), the concentrations of the acute phase 
proteins (APPs; i.e. lipopolysaccharide binding protein and haptoglobin) were measured in serum 
samples before and after challenge, and headspaces of pre- and post-inoculation serum samples 
were analysed using a conducting polymer based e-nose. Significant changes of certain e-nose 
sensor responses allowed discrimination between samples before and after challenge. The 
maximal changes in responses of sensitive e-nose sensors corresponded to the peak of clinical 
signs. Significant correlations linked decreasing responses of multiple e-nose sensors to 
increasing concentrations of APPs in the peripheral blood.  
 
 
Keywords: electronic nose, acute phase proteins (APP), animal model, gram-negative bacterial 
infection, Mannheimia haemolytica A1, host response 
 
Some results were partially shown at ISOEN 2009 (Italy, Brescia, 15-17.04.2009). 
*Manuscript
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1. Introduction 
From the past, it is well known that a number of infectious or metabolic processes could liberate 
specific odours characteristic of the disease indicating that there are significant relationships 
between diseases and alterations of the airborne chemicals emitted from the body. Based on this 
ancient knowledge, the diagnosis of infectious diseases on the basis of an altered profile of 
volatile organic compounds (VOCs) is a new area of clinical biochemistry and can therefore be 
used for the early detection of infectious diseases in both, veterinary and human medicine 
analysing readily collectable samples (i.e. blood, urine, exhaled breath, swabs). 
In human medicine, ‘artificial’ or ‘electronic’ nose (e-nose) technology has been employed in 
several areas of medical diagnosis, including rapid detection of tuberculosis [1],  Helicobacter 
pylori [2], bacterial sinusitis [3] and urinary tract infections [4, 5]. In veterinary medicine, the 
usefulness of e-nose technology was principally demonstrated for the first time in 2005 by 
discriminating serum samples obtained from badgers and cattle infected with Mycobacterium 
bovis from those obtained in non-infected controls [6]. The e-nose technology itself consists of 
an array of non-specific gas sensors. It functions in a manner similar to the olfactory system by 
‘smelling’ various classes of volatile compound. To distinguish VOC mixtures, complex data 
analysis is then used in order to classify a sample by pattern recognition. Despite these 
encouraging results, there is still a lack of knowledge about the source of VOCs detected. In the 
mammalian body, the composition of volatile gases may change significantly because of (i) the 
various speeds at which different metabolic products are removed from the blood, or (ii) the 
production of metabolic products arising from certain diseases or infection, either from the host 
response or the metabolising infective organism.  
The determination of acute phase proteins (APPs) is another diagnostic option that has 
been widely used in the last decades. The term ‘acute phase proteins’ describes a group of plasma 
proteins that are mainly synthesised in the liver and change in their concentrations substantially 
during the so called ‘acute phase reaction’, i.e. an early reaction of the host in response to many 
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different stimuli (such as infections, inflammation, tissue damage, immunological disorders or 
stress) [7]. The fact that circulating concentrations of APPs are measurable in the peripheral 
blood enables their use as quantifiable indicators of inflammation or infection. Over the last few 
decades, APPs have become biomarkers of choice in human medicine for monitoring 
inflammation and infection. In veterinary medicine, APPs are accepted biomarkers for infection 
and inflammation in experimental studies to reflect the acute phase response as an integral part of 
the innate immune system [8]. There is evidence that concentrations of serum APPs are related to 
the severity of underlying disease and therefore may act as markers of both the presence and the 
extent of disease [9].  
Mannheimia haemolytica (formerly Pasteurella haemolytica) is one of the most important 
gram-negative bacteria isolated from the respiratory tract in cattle. Gaining access to the lungs 
when host defences are compromised by stress or other infections, it is known to become a 
significant component of enzootic broncho-pneumonia in calves [10]. Especially in fatal bovine 
respiratory diseases of feedlot calves, M. haemolytica was the most common agent identified in 
peracute, acute, and subacute pathologic processes [11]. Experimental models of infection have 
been used for decades and for many reasons; for example to understand the pathogenesis of this 
particular bacterium in the bovine respiratory system [12-16], to determine the effect of 
treatments [17-19], or to develop different vaccination protocols [20-23]. In this experimental 
study, calves with Mannheimia haemolytica infection were used as a model to assess host 
response under the defined condition of a gram-negative bacterial infection in a natural host. 
Blood samples were collected before and after experimental challenge and were analysed for 
both (i) the concentration of APPs and (ii) the response characteristics of e-nose sensors due to 
VOCs present in the headspace of blood. First, we hypothesised that an e-nose can discriminate 
blood samples of animals obtained after infection from those obtained before infections. 
Secondly, we tested whether the measurable e-nose response could be correlated with the acute 
phase reaction generated in the host, because nothing is currently known about the relationship 
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between the acute phase reaction of the host and the change in its metabolic profile of VOCs. To 
the best of our knowledge this is the first study demonstrating that a changed VOC profile of 
serum headspace correlates with acute phase reaction in the host, following a pathogenic 
infection.   
 
2. Animals, material and methods 
2.1 Animals 
A cohort of 20 conventional cross-bred calves was used. Animals were introduced at the age of 3 
to 15 days and were housed in 4 groups (each group consisted of 5 calves) under controlled 
conditions according to the guidelines for animal welfare in the European Union. The calves 
were bedded on barley/wheat straw and fed with commercially available milk substitutes and 
coarse meal. Water and hay were supplied ad libitum. Daily clinical observations (including 
monitoring of respiratory rate, nasal secretions, ocular secretions, rectal temperature, appetite, 
and body weight) were used to confirm the clinical status of calves before they were included in 
the experiment. All phases of the study were performed at a specialised veterinary institute 
(Federal Research Institute for Animal Health, Germany) under supervision of a veterinarian, and 
had ethical approval from the Commission for the Protection of Animals of the state of Thuringia 
(registration number: 23-51/99). 
 
2.2 Experimental challenge and study design 
Aged 52  5  days (body weight: 64  6 kg, mean  SD), all calves were inoculated with 
Mannheimia haemolytica biotype A serotype 1 (M. haem. A1). As described by Schimmel in 
1987 [24], an 18-hour broth culture of M. haem. A1, strain 2353 (P588) was used for the 
experimental challenge resulting in an acute respiratory infection. Ten ml of the culture 
containing 1.5 - 2.0 x 10
9
 cfu per ml were administered intratracheally per calf and on two 
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consecutive days (the interval between the two inoculations was 30 hours). Surviving calves 
were euthanized for necropsy 5 days after the first inoculation of M. haem. A1.  
This study was designed as an intra-individually controlled study in order to decrease the 
number of animals used for experimental purposes for ethical reasons. Accordingly, the animals 
were their own controls considering the pre-infection data as a baseline. Thus, each animal was 
carefully and consecutively characterised before challenge (non-infected status or baseline data) 
as well as after challenge (infected status) by identical examinations and techniques. Daily 
clinical examinations were performed on each animal throughout the full study as explained 
above.  
 
2.3 Collection of blood and serum preparation 
Two blood samples were collected from each animal 7 days and one hour before experimental 
challenge. Eight blood samples were obtained post-inoculation (p.i): 3 h, 6 h, 12 h, 24 h, 48 h, 
3 d, 4 d, and 5 d after the first bacterial exposure. Jugular venous blood was collected using 
plastic syringes for serum production (S-Monovette®-Serum, Sarstedt AG & Co, Nuembrecht, 
Germany). Serum was harvested by centrifugation (20 minutes at 1500 g) and stored at -20°C until 
analysed.  
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2.4 E-nose headspace analyses 
In this study, a conducting polymer-based electronic nose containing an array of 13 sensors was 
used (e-nose, ST214, Scensive Tech. Ltd., Leeds, UK). Serum headspace was sampled using the 
static sampling method described previously [25]. Briefly, serum was defrosted and pipetted into 
Nalophan bags. Polypropylene tubes were inserted into the bags which were sealed at both ends. 
The bag volume was 0.75 litre and the sample volume was 900 µl. All bags were then filled with 
zero grade air and incubated for 15 minutes at 25°C. Time for adsorption and desorption during 
analyses was 20 seconds. The total time per replicate was 55 seconds. Seven replicates per 
sample were taken, and divergence (i.e. maximum amplitude of sensor signal in sample analysis) 
of replicates 3 to 5 were used for further analysis since they proved to be stable in flow [25]. All 
samples were blinded and analysed randomly. Ambient air temperature was kept constant at 
25°C. Three replicates were used for analysis.  
 
2.5. Analyses of acute phase proteins (APP) 
Lipopolysaccharide binding protein (LBP)  Concentrations of LBP in sera were measured 
using an enzyme-linked immunosorbent assay (ELISA) described elsewhere [26]. Intra- and 
inter-assay coefficients of variance were below 10%. The detection limit of the LBP assay was 
0.45 ng/mL.  
Haptoglobin (Hp)  Con entrations of Hp in sera were measured by means of an ELISA as 
described previously [26, 27]. The coating antibody was IgG (rabbit) anti-human haptoglobin 
(DAKO, Hamburg, Germany). The same antibody, but conjugated with horseradish peroxidise, 
was used as the detection reagent. Hp-standard was a calibrated bovine blood plasma. Calibration 
was done with a colorimetric assay (Tridelta Development Ltds., Greystones, Co., Wicklow, 
Irland) and also against purified bovine Hp isolated by affinity chromatography. The detection 
limit of the bovine haptoglobin ELISA was 0.8 µg/ml and the intra- and interassay coefficients of 
variance were less than 11%.  
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2.6 Statistical analyses 
Before applying any statistical test, all data were checked for normal distribution. Normally 
distributed data are expressed as mean  standard deviation (SD) while data without normal 
distribution are given as median and range (difference between minimum and maximum). 
Biological variation such as the individual calf, the infectious status (non-infected versus 
infected), and the time point of blood collection within the study, was also assessed for e-nose 
responses and APPs using mANOVA. Significant differences between datasets were identified 
using the multiple range test. Analysis of linear regression (Pearson) was used to identify linear 
correlations between two variables. Spearman rank correlation was applied when dealing with 
non-normally distributed data. The level of significance for all statistical methods applied was 
P ≤ 0.05. Results were displayed as ‘Box and Whisker’ plots. Outlier values are 1.5 to 3 times of 
the length of a box away from the median and extreme values are further away than 3 times of 
the length of the box. In addition, principle component analysis (PCA) was performed based on 
data averaged over all individuals in order to eliminate biological variability (Matlab 2006b 
including the PLS toolbox version 3.5, Eigenvector Inc.)). Consequently, three data points were 
available per time point of the experiment. One data point represented one replicate averaged 
over all subjects. Raw e-nose divergences and auto-scaled data were analysed using PCA. Auto-
scaling is a normalisation technique which scales all values of a column (e.g. for each sensor) by 
the standard deviation of each column of the matrix in order to eliminate different ranges in 
magnitudes between the columns.  
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3. Results  
3.1 Clinical course of the study 
After experimental inoculation, 6 of 20 calves (30%) died spontaneously before the end of the 
study. Four calves died between 24-48 hours, and two died between 48-72 hours after the first 
challenge with M. haem. A1.  
In surviving calves, the following clinical signs were dominant: within the first 6 hours 
after challenge the appetite dropped markedly and the majority of animals became quiet, dull or 
depressed; significant increases in respiratory rates were already observed within the first 3 hours 
and in rectal temperature within the first 6 hours after challenge. The maximum temperature was 
measured 2 days after challenge (Figure 1). Both rectal temperature and breathing frequency 
(data not shown) remained significantly increased in the group until the end of the study. 
Surviving calves (n = 14) were euthanized for necropsy at 5 d p.i. 
 
[INSERT figure 1 about HERE] 
 
3.2 Acute phase proteins (APP) 
Analysis of serum samples before infection (n = 40) showed concentrations of LBP of 
2.4 ± 2.2 µg/ml (mean ± SD) and 0.02 ± 0.04 mg/mL (mean ± SD) of Hp. After challenge with 
M. haem. A1, APPs increased significantly with the following time kinetics (Figure 2): for both 
LBP and Hp, the first significant increase was observed 12 hours p.i. Maximal concentrations 
were seen 24 and 48 hours p.i.. for LBP (about 600% of baseline data) and 48 hours p.i. for Hp. 
Significantly elevated concentrations of both APPs were measurable until the end of the 
observation period (5 d p.i.). A significant relationship was found between LBP and Hp as 
expressed by the coefficient of Spearman’s rank correlation of rsp = 0.73 (P < 0.0001, n = 178). 
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Rank correlations between rectal temperature and APPs were rsp = 0.51 (P < 0.0001, 
n = 178) for LBP, and rsp = 0.49 (P < 0.0001, n = 178) for Hp, both indicating significant 
relationships between the rise in body temperature and increased concentrations of APPs in the 
blood. 
 
[INSERT figure 2 about HERE]  
 
3.3 Response of e-nose sensors 
E-nose sensor responses of the complete array were analysed both in terms of changes due to the 
infection status (i.e. responses before and after experimental challenge) and over the time course 
of the study. Regarding the infection status, responses of sensors 3, 6 and 7 showed differences 
between all pre- and all post- inoculation samples (mANOVA, P < 0.05). Divergences of 
sensitive sensors became more negative after challenge.  
In terms of the time course, responses of sensors 2 to 8, 10 and 11 showed kinetic profiles as 
illustrated in Figure 3 as a typical example. In general, divergences of sensitive e-nose sensors 
were approximately the same before and shortly after challenge, then declined and reached a 
minimum at days 2 and 3 p.i., and increased again until the end of the study. However, responses 
of sensors 10 and 11 continued to decrease. This implies that there were a number of volatiles 
changing their concentrations in headspace in different ways during the course of infection, 
detected by the e-nose. 
 
[INSERT figure 3 about HERE] 
 
Performing PCA, no discrimination between time points were found due to the different ranges 
in magnitude of the sensors. After auto-scaling, a clear discrimination of time points 2 and 3 days 
after infection and the remaining data points were found. Principle component 1 and 2 covered in 
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total 92.62% of all variance. This discrimination was found on a group level when averaging 
over subjects and confirmed significant differences found using mANOVA and multiple range 
test for individual sensors without averaging.  
 
[INSERT figure 4 about HERE] 
 
3.4 Correlations between e-nose results, rectal temperature and acute phase proteins  
As shown in Table 1, significant correlations were found between responses of e-nose sensors 
and the severity of the infection expressed by either APP concentrations in the blood or rectal 
temperature. Strongest correlations were found between e-nose responses and the concentration 
of both APPs. With increasing concentrations of LBP, sensors 2-4 and 6-8 became more negative 
and sensors 10 and 11 became more positive. As the concentration of haptoglobin increased, 
responses of sensors 2-8 and sensor 13 became more negative. According to most of the sensor 
responses, the general temporal profile after infection was inversely proportional to increasing 
concentrations of APPs.  
The most negative responses of e-nose sensors were found 48 hours after challenge which 
corresponded to the highest peaks of Hp concentrations. In contrast, peaks in LBP concentrations 
were observed earlier, i.e. 24 hours after infection (see 3.2.). Therefore, coefficients of 
correlation between e-nose sensors and LBP were lower compared to those between e-nose 
sensors and haptoglobin.  
With respect to body temperature, only the responses of sensors 8 and 9 were 
significantly linked to fever; showing an increase in divergence with increasing rectal 
temperature. Coefficients of correlation were very low; ranging between 0.09 and 0.14. 
 
[INSERT table 1 about HERE] 
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4. Discussion 
The purpose of this study was (i) to assess the potential of electronic nose (e-nose) technology to 
detect differences in the patterns of volatile organic compounds (VOCs) released from the 
peripheral blood in an acute respiratory infection of calves, and (ii) to evaluate e-nose signals in 
comparison with the acute host response and rectal temperature; both known non-specific 
biomarkers of infectious or inflammatory diseases.  
The experimentally induced M. haemolytica challenge used in this study represents a 
bovine model of a severe bacterial infection with acute clinical illness and spontaneous deaths. 
Originally the study was performed to study the course of the disease and to develop potential 
medication but could also be used for assessing clinical symptoms and changes in headspace 
composition. There is evidence that bacterial lipopolysaccharide (LPS) was most likely heavily 
involved in the pathogenesis of acute host response because Mannheimia species belong to the 
group of gram-negative bacteria producing LPS, and because LPS binding protein (i.e. LBP) 
increased significantly after challenge (Fig. 2A). The fact that one third of the calves died within 
3 days after exposure reveals the well known phenomenon of limited ability of calves to tolerate 
LPS or even a hyperresponsiveness to endotoxin that has been described by others [28]. 
The systemic host response to infection includes the acute-phase response (APR) which is 
a highly conserved, complex, and non-specific series of immunological reactions that is mediated 
by pro-inflammatory cytokines and results in an entire array of metabolic and physiologic 
changes. One characteristic feature of APR after bacterial infection is a remarkable change in 
concentration of APPs [29]. Many of these APPs originate from the liver and represent 
alterations in the intermediary metabolism during the host defence to inflammation, injury and 
infection [7]. Being called ‘chemicals thermometers’, APPs respond in a close relationship to 
disease progression or recovery [8]. In this study, LBP and Hp, both accepted as major APPs in 
bovines [7, 26, 30], were used in addition to clinical symptoms (i.e. rectal temperature) in 
assessing the severity of the disease. While LBP has been assessed in the acute phase of 
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experimental infection models in bovine and porcine species so far [7, 31], Hp has also been 
identified as an useful diagnostic tool for detecting infectious respiratory diseases in calves even 
under field conditions [32]. 
 
Discrimination ability of the e-nose 
With the e-nose used in this experiment, clinically healthy cattle could be discriminated from 
challenged individuals with severe clinical symptoms. Significant differences in divergences in 
e-nose sensor array responses were found at the group level considering the median of groups per 
day. These differences obtained with sensors 3, 6 and 7 allowed discrimination between infected 
and non-infected individuals. Discrimination based on individual samples was not possible 
because of large variation across all sensors due to methodological factors and inconsistencies of 
the sensor surface associated with them [25]. Discrimination was also made difficult by the 
temporal changes in divergences over the course of the infection. Many sensors (e.g. 2 to 8, 10 
and 11) showed a significant decline at days 2 and 3 after challenge while responses obtained 
from other time points after infection were similar to pre-infection divergences. This minimised 
the total differences between all pre- and post challenge samples but on the other hand, this 
temporal profile reflected the progression of the infection.  
 The fact that e-nose sensor signals were reduced (i.e. decreasing reactions in e-nose 
response) after challenge is in good agreement with data reported from human medicine showing 
the ability of an electronic nose to detect changes in the human body odour as a result of renal 
dysfunction by reducing multivariate sensor signals [5, 33]. However, the biochemical 
background for both (i) the discrimination between infection and non-infection and (ii) the 
temporal profile after infection still remains unclear since it could not be elucidated in this study 
which molecules were responsible for the changes. To clarify this point, further analytical 
options and techniques are required (e.g. GC-MS). 
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Comparison between e-nose responses and the severity of the disease  
In this study, the severity of the experimentally induced bacterial infection was confirmed and 
characterised by clinical illness and spontaneous deaths. Body temperature and concentrations of 
APPs measurable in the peripheral blood provided additional quantitative assessment of the host 
response. Different APPs may show either an increase or a decrease in concentration following 
infection [7]. The two APPs included in this study, LBP and Hp, increased significantly after 
exposure to M. haem. A1. These findings confirm results from previous studies reporting an 
increased concentration of many APPs, including Hp and LBP, following an infection of the 
respiratory tract of calves with gram-negative bacteria (Pasteurella multocida or Mannheimia 
haemolytica) [34, 35]. 
 LBP and Hp were positively correlated with one another in this study and expressed 
similar temporal profiles over the experimental period. Interestingly, the correlation between 
LBP and Hp was stronger (rSP > 0.7) compared to the correlations between body temperature and 
each of the APPs (rSP  0.5). Nevertheless all three parameters reflected the APR in calves after 
bacterial infection with M. haem. A1, thus providing a good basis for the evaluation of responses of 
e-nose sensors.  
 The divergence of multiple sensors as a part of the e-nose array changed significantly 
over time comparing pre- and post challenge samples. Comparing the temporal profile of the 
e-nose responses with rectal temperature and APP concentrations revealed general correlations of 
several sensors and the surrogate markers for infection. Correlations between e-nose responses 
and LBP or Hp were more prominent compared to correlations between e-nose sensors and rectal 
temperature. However, correlation coefficients were low (rSP ≤ 0.20). This might be due to the fact 
that the temporal profile observed for each of e-nose signals, rectal temperature and APP 
concentrations were sometimes out of phase with one another, even though they were comparable 
in shape. Nevertheless, the correlation between the concentration of APPs as surrogate markers of 
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infection and e-nose sensor responses demonstrate the potential for VOC analysis by e-nose or 
other methods for monitoring and diagnosing infection and/or host response.  
 
Conclusions  
To the best of our knowledge, this is the first study evaluating e-nose technology by comparing 
responses with APPs in the peripheral blood.  
 E-nose analysis of the headspace of blood samples was shown to have potential for 
detecting animal infection. E-nose sensors allowed discrimination at the group level between 
pre-inoculation and post-inoculation samples in an animal model exposed to the gram-negative 
bacteria M. haem. A1. These findings warrant validation of e-noses in diagnosing different 
infections caused by different micro-organisms.  
 There are significant correlations between divergences of e-nose sensors and acute 
phase markers present in the blood of the infected host. The results are encouraging and provide 
the basis for the non-invasive detection of host responses based on the detection of VOCs. 
Further studies are required to identify VOCs that could be used as specific biomarkers for certain 
infections or diseases.  
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Table 1: Summary of Spearman’s rank correlation evaluating the relationship between responses 
of e-nose sensors and rectal temperature or blood concentrations of acute phase proteins, 
respectively  
 
Responses of e-nose 
sensors  
Rectal temperature 
in 
o
C 
c [LBP]  
in µg/ml 
c [Haptoglobin]  
in µg/ml 
rsp P rsp P rsp P 
Divergence sensor  01 0.0488 0.2737 0.0220 0.6211 -0.0091 0.8391 
Divergence sensor 02 0.0386 0.3871 -0.1255 0.0049 -0.1628 0.0003 
Divergence sensor 03 0.0755 0.0904 -0.1304 0.0034 -0.1264 0.0046 
Divergence sensor 04 0.0411 0.3564 -0.1101 0.0136 -0.1660 0.0002 
Divergence sensor 05 0.0515 0.2477 -0.0723 0.1050 -0.1257 0.0048 
Divergence sensor 06 0.0262 0.5563 -0.1057 0.0177 -0.1288 0.0039 
Divergence sensor 07 0.0331 0.4576 -0.1069 0.0165 -0.1335 0.0028 
Divergence sensor 08 0.0888 0.0465 -0.1059 0.0176 -0.1006 0.0241 
Divergence sensor 09 0.1398 0.0017 -0.0093 0.8348 -0.0046 0.9185 
Divergence sensor 10 0.0749 0.0930 0.1119 0.0121 0.0628 0.1590 
Divergence sensor 11 0.0839 0.0597 0.1223 0.0061 0.0776 0.0817 
Divergence sensor 12 0.0448 0.3148 0.0265 0.5525 -0.0427 0.3385 
Divergence sensor 13 0.0047 0.9153 -0.0239 0.5915 -0.1003 0.0244 
 
Legend to Table 1:  
rsp: coefficient of Spearman rank correlation.  
P  0.05 indicates significant correlations (highlighted in bold). 
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Figure captions and legends  
 
Figure 1: Rectal temperature measured in calves before and after an experimentally induced 
infection with Mannheimia haemolytica A1. Rectal temperature was highest 48 hours after 
infection.  
Legend:  
Box-and-Whisker Plot represents median value, 25% and 75% percentiles (box), range, outlier values ( ), and 
extreme values (*). Different letters indicate significant differences between time points (mANOVA). 
 
Figure 2: Concentrations of lipopolysaccharide binding protein (LBP, (A)) and haptoglobin (Hp, 
(B)) in serum samples collected before and after an experimentally induced infection with 
Mannheimia haemolytica A1 in calves. After infection, highest concentrations of acute phase 
proteins were measured 24 hours p.i. for LBP, and 48 hours p.i. for Hp.  
Legend:  
Box-and-Whisker Plot represents median value, 25% and 75% percentiles (box), range, outlier values ( ), and 
extreme values (*). Different letters indicate significant differences between time points (mANOVA). 
 
Figure 3: Changes of e-nose sensor 7 over time evaluating the headspace of serum samples 
obtained from calves before and after an experimentally induced infection with Mannheimia 
haemolytica A1. After infection, responses were significantly decreased and reached a minimum 
at days 2 and 3 p.i..  
Legend:  
Box-and-Whisker Plot represents median value, 25% and 75% percentiles (box) and range. Different letters indicate 
significant differences between time points (mANOVA).  
 
Figure 4: Principle component analysis of headspace serum samples. A clear discrimination was 
found between samples obtained at time points 2 and 3 (left) compared to remaining samples 
(right).  
Legend:  
Data was auto-scaled. The numbers next to data points indicate the sampling time.  
 
Figure captions
Page 23 of 27
Ac
ce
pte
d M
an
us
cri
pt
Table 1: Summary of Spearman’s rank correlation evaluating the relationship between 
responses of e-nose sensors and rectal temperature or blood concentrations of acute phase 
proteins, respectively 
Responses of e-nose 
sensors 
Rectal temperature
in oC
c [LBP] 
in µg/ml
c [Haptoglobin] 
in µg/ml
rsp P rsp P rsp P
Divergence sensor 01 0.0488 0.2737 0.0220 0.6211 -0.0091 0.8391
Divergence sensor 02 0.0386 0.3871 -0.1255 0.0049 -0.1628 0.0003
Divergence sensor 03 0.0755 0.0904 -0.1304 0.0034 -0.1264 0.0046
Divergence sensor 04 0.0411 0.3564 -0.1101 0.0136 -0.1660 0.0002
Divergence sensor 05 0.0515 0.2477 -0.0723 0.1050 -0.1257 0.0048
Divergence sensor 06 0.0262 0.5563 -0.1057 0.0177 -0.1288 0.0039
Divergence sensor 07 0.0331 0.4576 -0.1069 0.0165 -0.1335 0.0028
Divergence sensor 08 0.0888 0.0465 -0.1059 0.0176 -0.1006 0.0241
Divergence sensor 09 0.1398 0.0017 -0.0093 0.8348 -0.0046 0.9185
Divergence sensor 10 0.0749 0.0930 0.1119 0.0121 0.0628 0.1590
Divergence sensor 11 0.0839 0.0597 0.1223 0.0061 0.0776 0.0817
Divergence sensor 12 0.0448 0.3148 0.0265 0.5525 -0.0427 0.3385
Divergence sensor 13 0.0047 0.9153 -0.0239 0.5915 -0.1003 0.0244
Legend to Table 1: 
rsp: coefficient of Spearman rank correlation. 
P  0.05 indicates significant correlations (highlighted in bold).
Table(s)
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